Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.2265
Abstract: This cross-sectional study investigates the number of US Food and Drug Administration–approved cancer drugs that displaced standard-of-care therapies between 2016 and 2021. read more here.
Keywords: cancer; drug; therapies 2016; care therapies ... See more keywords